lamivudine oral
lamivudine oral is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including lamivudine. Available dosage form: solution.
Drug Details
- Generic Name
- lamivudine oral
- Brand Names
- lamivudine
- Application Number
- ANDA203564
- Sponsor
- Chartwell RX, LLC
- NDC Codes
- 2
- Dosage Forms
- SOLUTION
- Routes
- ORAL
- Active Ingredients
- LAMIVUDINE
Indications and Usage
1 INDICATIONS AND USAGE Lamivudine oral solution, USP is a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Limitations of Use: The dosage of this product is for HIV-1 and not for HBV. Lamivudine oral solution, USP is a nucleoside analogue reverse transcriptase inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. Limitations of Use: The dosage of this product is for HIV-1 and not for HBV. ( 1 )